Biochemical and haematological effects of a revised dosage schedule of phenylbutazone in horses.

The study analyzes the biochemical and hematological effects of a revised dosage plan for phenylbutazone – a common medicine used on horses, doubting its impact on significant changes in horse’s body.

Research Process

• The research involved two sets of five horses each. All horses formed pairs based on their similarities.
• In one group, all five horses were administered a daily dosage of phenylbutazone paste for twelve continuous days. The medicine’s formula went under revision as part of the research project.
• The second group of five horses was treated with a placebo preparation for the same duration to form a comparative study.

Finding and Results

• Throughout the study, the researchers recorded certain differences compared to the pre-treatment levels on both groups of horses. These differences were found to be statistically significant.
• However, these changes in the body (biochemical and hematological) represented inconsistencies in the baseline levels rather than the consequence of phenylbutazone administration.
• That is, these changes could not be directly attributed to the revised dosage schedule of phenylbutazone, questioning the relevance of dosage alteration.

Conclusion

• This research suggests that changes in horses after phenylbutazone administration might not be due to the medicine. Instead, these changes might originate from instability in baseline levels.
• It provides important insights into the effects of modifying dosage schedule of phenylbutazone, indicating that changes might not always derive from the medication per se. Further detailed investigations are required to ascertain the impacts of drug dosage variation.